A retrospective, multi-centre trial to evaluate the efficacy and safety of abacavir/lamivudine (Kivexa) plus rilpivirine in treatment naive HIV infected patients

Trial Profile

A retrospective, multi-centre trial to evaluate the efficacy and safety of abacavir/lamivudine (Kivexa) plus rilpivirine in treatment naive HIV infected patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2016

At a glance

  • Drugs Lamivudine/abacavir (Primary) ; Rilpivirine (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top